EMA Grants First Two PRIME Designations In 2024 To Ultragenyx & Sangamo

 
• By Neena Brizmohun
  
The PRIME scheme aims to help developers of medicines for unmet medical needs • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography